SCM
AARD

Suvretta Capital Management’s Aardvark Therapeutics, Inc. Common Stock AARD Stock Holding History

Suvretta Capital Management’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-312,500
Closed -$2.35M – 110
2025
Q1 		$2.35M Buy
+312,500
New +$2.35M 0.09% 73